This content is only available within our institutional offering.
20 Apr 2016
Conviction List Q2 2016
Allergy Therapeutics plc (AGY:LON), 2.8 | Character Group plc (CCT:LON), 277 | Epwin Group PLC (EPWN:LON), 85.5 | Fenner (FENR:LON), 0 | Hansard Global plc (HSD:LON), 48.3 | Merlin Entertainments (MERL:LON), 0 | Pantheon Resources plc (PANR:LON), 32.4 | Reach plc (RCH:LON), 69.0 | Gemfields Group Limited (GEM:LON), 11.4
Sign in
This content is only available to commercial clients. Sign in if you have access or contact support@research-tree.com to set up a commercial account
This content is only available to commercial clients. Sign in if you have access or contact support@research-tree.com to set up a commercial account
Conviction List Q2 2016
Allergy Therapeutics plc (AGY:LON), 2.8 | Character Group plc (CCT:LON), 277 | Epwin Group PLC (EPWN:LON), 85.5 | Fenner (FENR:LON), 0 | Hansard Global plc (HSD:LON), 48.3 | Merlin Entertainments (MERL:LON), 0 | Pantheon Resources plc (PANR:LON), 32.4 | Reach plc (RCH:LON), 69.0 | Gemfields Group Limited (GEM:LON), 11.4
- Published:
20 Apr 2016 -
Author:
Barrie Cornes -
Pages:
54